PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Critical Care, St Michael\'s Hospital, Toronto, Ontario, Canada.\', \'Departments of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada.\', \'Division of Rheumatology, St. Michael\'s Hospital, Toronto, Ontario, Canada.\', \'Keenan Centre for Biomedical Research, Li Ka Shing Knowledge Institute, St Michael\'s Hospital, Toronto, Ontario, Canada.\', \'Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.\', \'Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada fritzler@ucalgary.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-220206
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 33903092
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
?:title
  • Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all